MA Kuang Healthcare Holding (4139) Monthly Revenue

Market: TPEx (OTC) · Industry: Biotech & Medical · 馬光-KY

MA Kuang Healthcare Holding (4139) reported revenue of NT$95.7 million for Oct 2026, +7.3% year on year and +6.0% from the previous month. Revenue for Jan–Oct 2026 was NT$901 million (+1.2% year on year).

Year-on-year revenue growth: 4 months in a row. →

In Oct 2026, it ranked No. 76 by revenue among 160 Biotech & Medical companies.

Monthly revenue chart

Oct 2024 NT$102 million24/10Nov 2024 NT$91.7 millionDec 2024 NT$108.9 millionJan 2025 NT$78.5 millionFeb 2025 NT$85.3 million25/02Mar 2025 NT$100 millionApr 2025 NT$92 millionMay 2025 NT$90.7 millionJun 2025 NT$90.7 million25/06Jul 2025 NT$85.4 millionAug 2025 NT$90.3 millionSep 2025 NT$87.9 millionOct 2025 NT$89.1 million25/10Nov 2025 NT$93.8 millionDec 2025 NT$108.6 millionJan 2026 NT$90.4 millionFeb 2026 NT$72.4 million26/02Mar 2026 NT$91.5 millionApr 2026 NT$91.6 millionMay 2026 NT$96.3 millionJun 2026 NT$89.5 million26/06Jul 2026 NT$90.5 millionAug 2026 NT$93 millionSep 2026 NT$90.3 millionOct 2026 NT$95.7 million26/10

Hover over (or tap) a bar to see that month’s revenue.

Monthly revenue history

MonthRevenueYoYMoM
Oct 2026NT$95.7 million+7.3%+6.0%
Sep 2026NT$90.3 million+2.7%-3.0%
Aug 2026NT$93 million+3.1%+2.8%
Jul 2026NT$90.5 million+6.0%+1.2%
Jun 2026NT$89.5 million-1.4%-7.1%
May 2026NT$96.3 million+6.2%+5.1%
Apr 2026NT$91.6 million-0.5%+0.2%
Mar 2026NT$91.5 million-8.6%+26.4%
Feb 2026NT$72.4 million-15.1%-19.9%
Jan 2026NT$90.4 million+15.2%-16.8%
Dec 2025NT$108.6 million-0.2%+15.8%
Nov 2025NT$93.8 million+2.3%+5.3%
Oct 2025NT$89.1 million-12.6%+1.4%
Sep 2025NT$87.9 million-12.6%-2.6%
Aug 2025NT$90.3 million-10.0%+5.7%
Jul 2025NT$85.4 million-7.7%-5.8%
Jun 2025NT$90.7 million+5.0%+0.0%
May 2025NT$90.7 million+2.8%-1.5%
Apr 2025NT$92 million-5.7%-8.0%
Mar 2025NT$100 million+1.7%+17.3%
Feb 2025NT$85.3 million+22.2%+8.7%
Jan 2025NT$78.5 million-15.1%-27.9%
Dec 2024NT$108.9 million-13.9%+18.7%
Nov 2024NT$91.7 million-6.2%-10.0%
Oct 2024NT$102 million-1.5%+1.4%

Jan–Oct 2026 cumulative: NT$901 million (+1.2% YoY)

History covers months since this site began collecting, plus prior-month and prior-year figures in each release. It grows every month.

Other Biotech & Medical companies

Compare with peers: MA Kuang Healthcare Holding vs PEC / MA Kuang Healthcare Holding vs Lotus Pharm / MA Kuang Healthcare Holding vs Bora

CompanyRevenueYoY
PEC6446NT$2.84 billion+102.0%
Lotus Pharm1795NT$2.13 billion-22.5%
Bora6472NT$1.99 billion+15.9%
Great Tree Pharmacy6469NT$1.67 billion+1.5%
EXCELSIOR4104NT$1.02 billion+38.6%
PEGAVISION6491NT$793 million+13.0%
Synmosa Biopharma4114NT$766.6 million+41.2%
Y.S.H.3705NT$749.4 million+4.4%

Company remark (original Chinese)

本公司合併營收數為公司自結數

See also

← All Taiwan listed & OTC companies

Sources: Taiwan Stock Exchange, monthly revenue of listed companies (Government Open Data Platform); Taipei Exchange, monthly revenue of OTC companies (TPEx OpenAPI); historical months from MOPS. Amounts in New Taiwan dollars. Changes calculated by this site from the source figures. Not investment advice. Updated: 2026-11-16